Thomas Sciascia

Thomas Sciascia

Net worth: 4 M $ as of 2026-06-29

72 year
Health Technology
Consumer Services
Commercial Services

Profile

Thomas R.
Sciascia
is the founder of Trevi Therapeutics, Inc., founded in 2011, serving as Chief Scientific Officer since 2022.
Former jobs include Medical Director at Quintiles, Inc. (California) from 1997 to 2000, Medical Director at Transkaryotic Therapies, Inc. from 2000 to 2001, Chief Medical Officer & Senior Vice President at Penwest Pharmaceuticals Co. from 2001 to 2010, and Faculty Member at Boston University from 1983 to 1997.
Education includes a doctorate from The Trustees of Columbia University in The City of New York in 1979 and an undergraduate degree from Massachusetts Institute of Technology in 1975.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-18 221,373 ( 0.16% ) 4 M $ 2026-06-29

Thomas Sciascia active positions

CompaniesPositionStart
TREVI THERAPEUTICS, INC. Founder 2010-12-31

Former positions of Thomas Sciascia

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 2000-12-31
Chief Tech/Sci/R&D Officer 1999-12-31
Corporate Officer/Principal 1996-12-31
Chief Tech/Sci/R&D Officer -
See the detail of Thomas Sciascia's experience

Training of Thomas Sciascia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Commercial Services

Health Technology

Health Services

Consumer Services

Consumer Services

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Thomas Sciascia